Table 4. Analysis of Molecular Variance (AMOVA) of Asian C. neoformans according to HIV status and geographical origin.
d.f. | Sum of Squares | Variance components (%) | p-value | |
Clinical isolates: HIV-positive (n = 227), HIV-negative(n = 135), unknown HIV status (n = 47) | ||||
Among populations | 2 | 109.66 | 0.44 (11.62) | |
Within populations | 406 | 1364.16 | 3.36 (88.38) | |
Total | 408 | 1473.82 | 3.80 (100) | 0.0000 |
Isolates from HIV-positive patients : East Asia (n = 8), Middle East (n = 5), South/Southeast Asia (n = 214) | ||||
Among populations | 2 | 14.37 | 0.30 (7.95) | |
Within populations | 224 | 775.92 | 3.46 (92.05) | |
Total | 226 | 790.29 | 3.76 (100) | 0.0654±0.0025 |
Isolates from HIV-negative patients : East Asia (n = 99), Middle East (n = 10), South/Southeast Asia (n = 26) | ||||
Among populations | 2 | 199.54 | 3.39 (63.20) | |
Within populations | 132 | 260.46 | 1.97 (36.80) | |
Total | 134 | 460.00 | 5.36 (100) | 0.0000 |